AIDs Clinical Trials 2022

Browse 132 Aids Medical Studies Across 119 Cities
14 Phase 3 Trial · 456 Aids Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials AIDs Clinical Trials 2022

Reviewed by Michael Gill, B. Sc.

Image of Beth Israel Deaconess Medical Center in Boston, United States.

Phase-Based Progress Estimates

MVA-BN-HIVfor Acquired Immunodeficiency Syndrome

FDA Approved Drug

This trial is studying a possible HIV vaccine.

FDA Approved Drug

Beth Israel Deaconess Medical CenterBoris D Juelg, MD PHDJanssen Pharmaceuticals

Image of University of Pittsburgh Cancer Institute (UPCI) in Pittsburgh, United States.

Phase-Based Progress Estimates

Cabozantinib S-malatefor Breast

FDA Approved Drug

This trial is investigating the side effects of two drugs, cabozantinib and nivolumab, in treating patients with advanced cancer who are also undergoing treatment for HIV.

FDA Approved Drug

University of Pittsburgh Cancer Institute (UPCI) (+1 Sites)Haiying Cheng

Image of John A. Burns School of Medicine, University of Hawaii - Manoa in Honolulu, United States.

Phase-Based Progress Estimates

Metforminfor HIV Infections

FDA Approved Drug

This trial is testing if the diabetes medication metformin can improve the health of people with HIV who are taking antiretroviral therapy (ART).

FDA Approved Drug

John A. Burns School of Medicine, University of Hawaii - ManoaCecilia M Shikuma, MDMerck Sharp & Dohme LLC

Image of Samir Gupta in Indianapolis, United States.

Phase-Based Progress Estimates

JULUCA 50Mg-25Mg Tabletfor HIV Infections

FDA Approved Drug

This trial will compare how well the drugs in JULUCA work in HIV-negative patients who require hemodialysis, compared to those with normal renal function.

FDA Approved Drug

Samir GuptaSamir K Gupta, MD

Image of Emory Children's Center ( Site 0103) in Atlanta, United States.

Phase-Based Progress Estimates

Doravirinefor HIV Infections

FDA Approved Drug

This trial is evaluating the safety and efficacy of an experimental drug for HIV in children.

FDA Approved Drug

Emory Children's Center ( Site 0103)Medical DirectorMerck Sharp & Dohme LLC

Image of Children's Hospital Colorado in Aurora, United States.

Phase-Based Progress Estimates

Arm A: Rapid Start Groupfor Acquired Immunodeficiency Syndrome

FDA Approved Drug

This trial will compare starting HIV treatment immediately to waiting until later.

FDA Approved Drug

Children's Hospital Colorado (+2 Sites)Hillary Dunlevy, MDGilead Sciences

Image of Midway Immunology and Research /ID# 215587 in Fort Pierce, United States.

Phase-Based Progress Estimates

ABBV-181for Antibody Deficiency Syndrome

Waitlist Available

No Cost For Treatment

This trial will test the safety and effectiveness of ABBV-181 in HIV-1 infected people who are taking a break from their usual antiretroviral therapy.

Waitlist Available

No Cost For Treatment

Midway Immunology and Research /ID# 215587 (+13 Sites)ABBVIE INC.AbbVie

Image of NYU Langone Health in New York, United States.

Phase-Based Progress Estimates

Counseling + Nicotine Replacement Therapies NRTfor Acquired Immunodeficiency Syndrome

FDA Approved Drug

This trial will test if e-cigarettes are more effective than nicotine replacement therapy in reducing cigarette smoking for adults with HIV/AIDS.

FDA Approved Drug

NYU Langone HealthOmar El Shahawy, MD

Image of Johns Hopkins University in Baltimore, United States.

Phase-Based Progress Estimates

Tenofovir Douchefor HIV Infections

This trial is testing different ways of using a rectal douche before and after simulated receptive anal intercourse, to see how well it protects against HIV acquisition.

Johns Hopkins UniversitySridhar Nimmagadda, PhD

Image of Northwestern University in Chicago, United States.

Phase-Based Progress Estimates

Standard Treatment + Managed Problem Solving (MAPS) Adherence Interventionfor Nicotine Dependence

FDA Approved Drug

This trial will test the efficacy of varenicline, in combination with nicotine replacement therapy (NRT), compared to varenicline alone, for smoking cessation among PLWHA.

FDA Approved Drug

Northwestern University (+1 Sites)

Image of San Francisco General Hospital in San Francisco, United States.

Phase-Based Progress Estimates

Oral Methamphetaminefor HIV Infections

FDA Approved Drug

This trial will study the effects of short-term methamphetamine exposure in HIV-infected individuals on residual virus production, gene expression, and inflammation.

FDA Approved Drug

San Francisco General HospitalSulggi A Lee, MD PhD

Image of Atlanta Veterans Health Care System in Decatur, United States.

Phase-Based Progress Estimates

Project TRAC: Tracking And Reducing Alcohol Consumptionfor Alcohol Drinking

This trial will aim to reduce alcohol use among people living with HIV/AIDS, in order to improve treatment adherence and outcomes.

Atlanta Veterans Health Care SystemCarolyn Lauckner, PhD

Image of National Institutes of Health Clinical Center in Bethesda, United States.

Phase-Based Progress Estimates

Pembrolizumabfor HIV Infections

FDA Approved Drug

This trial is testing a new drug to see if it's safe to use in people with HIV who have a low CD4+ T cell count, and to see if it strengthens the immune system.

FDA Approved Drug

National Institutes of Health Clinical CenterJoseph A Kovacs, M.D.

Image of National Institutes of Health Clinical Center in Bethesda, United States.

Phase-Based Progress Estimates

Pembrolizumabfor HIV Infections

FDA Approved Drug

This trial is for people with HIV to see if the cancer drug pembrolizumab is safe, not to treat HIV.

FDA Approved Drug

National Institutes of Health Clinical CenterAvindra Nath, M.D.

Image of San Francisco General Hospital in San Francisco, United States.

Phase-Based Progress Estimates

Alirocumabfor HIV Infections

FDA Approved Drug

This trial will study whether a drug that lowers cholesterol can also reduce inflammation and improve endothelial function in people with HIV.

FDA Approved Drug

San Francisco General HospitalPriscilla Hsue, MD

Image of GSK Investigational Site in Birmingham, United States.

Phase-Based Progress Estimates

Cabotegravir - Injectable Suspension (CAB LA)for HIV Infections

Waitlist Available

FDA Approved Drug

This trial is testing whether an injection of two drugs every month can effectively suppress HIV in people who are already taking daily pills to control the virus.

Waitlist Available

FDA Approved Drug

GSK Investigational Site (+35 Sites)GSK Clinical TrialsViiV Healthcare

Image of M D Anderson Cancer Center in Houston, United States.

Phase-Based Progress Estimates

Allogeneic BK-specific Cytotoxic T-lymphocytesfor Viral Encephalitis

This trial is testing how well cytotoxic T lymphocytes from donors can treat patients with cancer caused by BK or JC viruses.

M D Anderson Cancer CenterAmanda Olson

Image of GSK Investigational Site in Birmingham, United States.

Phase-Based Progress Estimates

GSK744 LAfor HIV Infections

Waitlist Available

FDA Approved Drug

This trial is testing an injectable drug combination to see if it is more effective, safe, and tolerable than an oral drug combination in HIV-1 infected people who have not taken antiretroviral drugs before.

Waitlist Available

FDA Approved Drug

GSK Investigational Site (+19 Sites)GSK Clinical TrialsJanssen Pharmaceuticals

Image of University of South Florida in Tampa, United States.

Phase-Based Progress Estimates

DRVfor HIV Infections

FDA Approved Drug

This trial will investigate the safety and pharmacokinetics of two HIV medications, Atazanavir and Darunavir, in children and adolescents.

FDA Approved Drug

University of South Florida (+1 Sites)Gilead Study DirectorGilead Sciences

Image of Miller's Children Hospital in Long Beach, United States.

Phase-Based Progress Estimates

E/C/F/TAFfor HIV Infections

Waitlist Available

FDA Approved Drug

This trial is studying a four-drug combination pill to treat HIV-1 in adolescents and children. The objectives are to evaluate the safety and tolerability of the pill and to study how it is processed by the body.

Waitlist Available

FDA Approved Drug

Miller's Children Hospital (+4 Sites)Gilead Study DirectorGilead Sciences

Image of UC San Diego Moores Cancer Center in La Jolla, United States.

Phase-Based Progress Estimates

Cabozantinib S-malatefor Unresectable Solid Neoplasm

Waitlist Available

FDA Approved Drug

This trial is testing the effects of cabozantinib s-malate on patients with solid tumors that have spread and usually can't be cured or controlled. Cabozantinib s-malate may stop tumor cell growth by blocking some enzymes needed for cell growth.

Waitlist Available

FDA Approved Drug

UC San Diego Moores Cancer Center (+20 Sites)Missak Haigentz

Image of Children's Hospital Los Angeles in Los Angeles, United States.

Phase-Based Progress Estimates

Maravirocfor Acquired Immunodeficiency Syndrome

Waitlist Available

FDA Approved Drug

This trial will study the effects of the drug maraviroc in HIV-1 infected children and adolescents, in order to determine a safe dosage schedule.

Waitlist Available

FDA Approved Drug

Children's Hospital Los Angeles (+17 Sites)Pfizer CT.gov Call CenterViiV Healthcare

Image of United States Army Research Institute of Environmental Medicine in Natick, United States.

Phase-Based Progress Estimates

Ibuprofen 800 Mgfor Bone Resorption

This trial will test the effects of NSAIDs on post-workout bone and muscle health.

United States Army Research Institute of Environmental Medicine

Image of University of Louisville Hospital in Louisville, United States.

Phase-Based Progress Estimates

NSAIDsfor Traumas

This trial will compare the effects of two different pain management methods on patients recovering from surgery.

University of Louisville Hospital (+1 Sites)Rodolfo Zamora, MD

Image of The State University of New York at Buffalo in Buffalo, United States.

Phase-Based Progress Estimates

Amplification-onlyfor Tinnitus

This trial is testing whether hearing aids with an added sound can help people with tinnitus.

The State University of New York at BuffaloWei Sun, Ph.D.Sonova AG

25 Aids Clinical Trials Near Me

Top Hospitals for Aids Clinical Trials

Image of Boston Medical Center in Massachusetts.

Boston Medical Center

Boston

3Active Trials

8All Time Trials for Aids

2009First Aids Trial

Image of Emory University in Georgia.

Emory University

Atlanta

3Active Trials

9All Time Trials for Aids

2014First Aids Trial

Top Cities for Aids Clinical Trials

Image of New York in New York.

New York

44Active Trials

NYU Langone HealthTop Active Site

Image of Atlanta in Georgia.

Atlanta

20Active Trials

Emory UniversityTop Active Site

Aids Clinical Trials by Phase of Trial

Phase < 1 Aids Clinical Trials

2Active Aids Clinical Trials

2Number of Unique Treatments

2Number of Active Locations

Intervention Group - Ketorlac (NSAID)Game Plan for PrEP

Aids Clinical Trials by Age Group

< 18 Aids Clinical Trials

7Active Aids Clinical Trials

Doravirine DRV E/C/F/TAF REMUNE Acetaminophen and Ibuprofen Bolstered Standard of Care (BSOC)PHAT Life: Preventing HIV/AIDS Among Teens--YR Arm

Most Recent Aids Clinical Trials

Clinical Trial

Began Recruiting Date

Phase

3BNC117-LS for Acquired Immunodeficiency Syndrome

11/15/2022

Phase 1

LetSync v1.0 for Acquired Immunodeficiency Syndrome

11/15/2022

N/A

Care Post Clinic-Wide Training and HIV Prevention Decision Support Tool (DST) for HIV

11/9/2022

N/A

Letermovir for HIV Infections

11/2/2022

Phase 2

Low Dose Naltrexone for Pain

11/1/2022

Phase 4

Top Treatments for Aids Clinical Trials

Treatment Name

Active Aids Clinical Trials

All Time Trials for Aids

First Recorded Aids Trial

Cabozantinib S-malate

2

2

2013

Tenofovir Douche

2

2

2021

Pembrolizumab

2

2

2018

MVA-BN-HIV

1

1

2022

Metformin

1

2

2016

Recently Completed Studies with FDA Approved Treatments for Aids

Treatment

Year

Sponsor

DRV/COBI FDC

2022

Janssen Research & Development, LLC

Budigalimab

2021

AbbVie

Tenofovir Disoproxil Fumarate

2021

Eastern Virginia Medical School

Relapse Prevention Text Messaging

2019

VA Office of Research and Development

Switch to E/C/FTC/TAF daily

2019

University of California, Los Angeles

About The Author

Michael Gill - B. Sc.

First Published: October 26th, 2021

Last Reviewed: October 29th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.